flecainide has been researched along with ajmaline in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (18.18) | 18.7374 |
| 1990's | 2 (9.09) | 18.2507 |
| 2000's | 6 (27.27) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Heinemeyer, G; Köppel, C; Oberdisse, U | 1 |
| Agena, H; Andresen, D; Schröder, R; Theiss, A; von Leitner, ER; Wegscheider, K | 1 |
| Somberg, J | 1 |
| Bobba, P; Chimienti, M; Guasti, L; Klersy, C; li Bergolis, M; Marangoni, E; Moizi, M; Morellini, MC; Salerno, JA; Tronconi, L | 1 |
| Somberg, JC | 1 |
| Lüderitz, B; Manz, M | 1 |
| Barra, N; Cellarier, G; Chalvidan, T; Colin, R; Deharo, JC; Djiane, P; Peyre, JP; Savon, N | 1 |
| Bella, PD; Carbucicchio, C; Schmidinger, H; Stix, G | 1 |
| Antzelevitch, C; Fish, JM | 1 |
| Antzelevitch, C; Borggrefe, M; Echternach, C; Haase, KK; Kuschyk, J; Schimpf, R; Spehl, S; Streitner, F; Thomas, GP; Veltmann, C; Wolpert, C | 1 |
| Nattel, S | 1 |
| Arentz, T; Astheimer, K; Kalusche, D; Letsas, KP; Weber, R | 1 |
| Allocca, G; Baritussio, A; Basso, C; Buja, G; Corrado, D; Delise, P; Iliceto, S; Leoni, L; Marinelli, A; Marras, E; Migliore, F; Perazzolo Marra, M; Thiene, G; Zorzi, A | 1 |
| Acket, B; Arne-Bès, MC; Audoubert, M; Cardin, C; Carrié, D; Chiriac, AM; Cintas, P; Davy, JM; Delay, M; Duparc, A; Galinier, M; Maury, P; Mondoly, P; Pasquié, JL; Raczka, F; Rollin, A; Sadron, M; Zhao, X | 1 |
| Akin, I; Behnes, M; Borggrefe, M; Dworacek, J; El-Battrawy, I; Lang, S; Liebe, V; Meister, S; Patocskai, B; Rudic, B; Tiburcy, M; Tülümen, E; Utikal, J; Wieland, T; Yücel, G; Zhao, Z; Zhou, XB; Zimmermann, WH | 1 |
| Bassi, F; Bernardi, G; Dametto, E; Livi, U; Maiani, M; Napolitano, C; Poli, S; Proclemer, A; Rebellato, L; Toniolo, M; Vendramin, I; Zanuttini, D | 1 |
| Babuty, D; Barc, J; Dupuis, JM; Gourraud, JB; Guyomarch, B; Jesel, L; Kyndt, F; Le Marec, H; Mabo, P; Mansourati, J; Martins, R; Maury, P; Pasquie, JL; Petit, B; Probst, V; Redon, R; Sacher, F; Schott, JJ; Therasse, D; Thollet, A | 1 |
| Akin, I; Borggrefe, M; El-Battrawy, I; Lang, S; Zhou, X | 1 |
| Bernus, O; Cheniti, G; Combes, N; Derval, N; Duchateau, J; Escande, W; Gandjbakhch, E; Gourraud, JB; Haissaguerre, M; Hermida, JS; Hocini, M; Jaïs, P; Krisai, P; Lavergne, T; Martins, R; Maury, P; Merino, JL; Nademanee, K; Pambrun, T; Pasquié, JL; Postema, PG; Probst, V; Sacher, F; Surget, E; Vigmond, E | 1 |
| Chokesuwattanaskul, R; Leelapatana, P; Prechawat, S; Rungpradubvong, V; Thapanasuta, M | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
4 review(s) available for flecainide and ajmaline
| Article | Year |
|---|---|
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Flecainide; Humans; Imidazoles; Pre-Excitation Syndromes; Propafenone; Quinidine; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil | 1993 |
Management of untreatable ventricular arrhythmias during pharmacologic challenges with sodium channel blockers for suspected Brugada syndrome.
Topics: Action Potentials; Adolescent; Adult; Aged; Aged, 80 and over; Ajmaline; Brugada Syndrome; Cardiopulmonary Resuscitation; Child; Electrocardiography; Extracorporeal Membrane Oxygenation; Female; Flecainide; Heart Arrest; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Sodium Channel Blockers; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation; Young Adult | 2018 |
Malignant Purkinje ectopy induced by sodium channel blockers.
Topics: Adult; Ajmaline; Catheter Ablation; Electrocardiography; Flecainide; Humans; Male; Middle Aged; Reproducibility of Results; Sodium Channel Blockers; Tachycardia, Ventricular; Ventricular Premature Complexes | 2022 |
1 trial(s) available for flecainide and ajmaline
| Article | Year |
|---|---|
[Comparative study of the anti-arrhythmia effect of flecainide acetate and prajmalium bitartrate in patients with tachycardiac ventricular rhythm disorders].
Topics: Adult; Aged; Ajmaline; Cardiac Complexes, Premature; Clinical Trials as Topic; Electrocardiography; Female; Flecainide; Heart Ventricles; Humans; Male; Middle Aged; Prajmaline; Random Allocation; Tachycardia | 1986 |
17 other study(ies) available for flecainide and ajmaline
| Article | Year |
|---|---|
Clinical course and outcome in class IC antiarrhythmic overdose.
Topics: Ajmaline; Anti-Arrhythmia Agents; Bicarbonates; Bradycardia; Drug Overdose; Flecainide; Hemoperfusion; Humans; Hypertonic Solutions; Nausea; Prajmaline; Propafenone; Resuscitation; Retrospective Studies; Sodium; Sodium Bicarbonate; Tachycardia; Vomiting | 1990 |
[Intravenous flecainide in Wolff-Parkinson-White syndrome: a test for evaluation of the refractory period of the anomalous pathway. Comparison with ajmaline].
Topics: Adolescent; Adult; Aged; Ajmaline; Child; Female; Flecainide; Heart Conduction System; Humans; Infusions, Intravenous; Male; Middle Aged; Regression Analysis; Wolff-Parkinson-White Syndrome | 1988 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
His-Purkinje system reentry as a proarrhythmic effect of flecainide.
Topics: Administration, Oral; Aged; Ajmaline; Anti-Arrhythmia Agents; Bundle of His; Bundle-Branch Block; Electrocardiography; Female; Flecainide; Humans; Infusions, Intravenous; Purkinje Fibers; Tachycardia, Ventricular | 2000 |
Spatial and temporal heterogeneity of depolarization and repolarization may complicate implantable cardioverter defibrillator therapy in Brugada syndrome.
Topics: Adrenergic beta-Agonists; Adult; Ajmaline; Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiac Pacing, Artificial; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography; Exercise Test; Female; Flecainide; Humans; Injections, Intravenous; Male; Metaproterenol; Middle Aged; Recurrence; Syndrome; Ventricular Fibrillation | 2000 |
Role of sodium and calcium channel block in unmasking the Brugada syndrome.
Topics: Ajmaline; Animals; Bundle-Branch Block; Calcium Channel Blockers; Dogs; Electrocardiography; Flecainide; Procainamide; Sodium Channel Blockers; Terfenadine; Verapamil | 2004 |
Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome.
Topics: Ajmaline; Animals; Anti-Arrhythmia Agents; Bundle-Branch Block; Dogs; Electrocardiography; Flecainide; Heart Conduction System; Humans; Myocytes, Cardiac; Patch-Clamp Techniques; Prospective Studies; Sodium Channel Blockers | 2005 |
Are all sodium channel blockers created equal? Clinical-basic correlations based on observations in Brugada syndrome.
Topics: Ajmaline; Anti-Arrhythmia Agents; Bundle-Branch Block; Electrocardiography; Flecainide; Heart Conduction System; Humans; Sodium Channel Blockers | 2005 |
Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype.
Topics: Adult; Ajmaline; Anti-Arrhythmia Agents; Biomarkers; Brugada Syndrome; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Risk Factors; Tachycardia, Ventricular; Ventricular Fibrillation | 2010 |
Should all individuals with a nondiagnostic Brugada-electrocardiogram undergo sodium-channel blocker test?
Topics: Adult; Ajmaline; Anti-Arrhythmia Agents; Brugada Syndrome; Diagnosis, Differential; Diagnostic Errors; Dose-Response Relationship, Drug; Electrocardiography; Exercise Test; Female; Flecainide; Follow-Up Studies; Humans; Incidence; Infusions, Intravenous; Italy; Male; Prognosis; Prospective Studies; Risk Assessment; Sodium Channel Blockers; Time Factors | 2012 |
Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
Topics: Adult; Ajmaline; Brugada Syndrome; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography; Female; Flecainide; Follow-Up Studies; France; Humans; Incidence; Male; Myotonic Dystrophy; Prevalence; Prognosis; Prospective Studies; Survival Rate; Voltage-Gated Sodium Channel Blockers | 2014 |
Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Topics: Ajmaline; Flecainide; Hot Temperature; Humans; Lidocaine; Myocytes, Cardiac; Patch-Clamp Techniques; Pluripotent Stem Cells; Polymerase Chain Reaction; Ranolazine; Sodium Channel Blockers; Sodium Channels | 2016 |
Sodium-channel blocker challenge in the familial screening of Brugada syndrome: Safety and predictors of positivity.
Topics: Adult; Ajmaline; Brugada Syndrome; Dose-Response Relationship, Drug; Electrocardiography; False Positive Reactions; Female; Flecainide; Follow-Up Studies; Heart Rate; Humans; Injections, Intravenous; Male; Prognosis; Retrospective Studies; Voltage-Gated Sodium Channel Blockers | 2017 |
Sodium channel blockers in Brugada syndrome.
Topics: Ajmaline; Brugada Syndrome; Flecainide; Humans; Sodium Channel Blockers; Syncope | 2018 |
T-Peak to T-End Interval for Prediction of Positive Response to Ajmaline Challenge Test in Suspected Brugada Syndrome Patients.
Topics: Ajmaline; Brugada Syndrome; Flecainide; Humans; Procainamide; Sodium Channel Blockers | 2022 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |